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Abstract
The human embryonic stem cell line RCe015-A (RC-11) was derived under quality assured compliance with UK regulation, European Union Directives and International guidance for tissue procurement, processing and storage according to Good Manufacturing Practice (GMP) standards. The cell line was derived from a fragmented cleavage stage embryo voluntarily donated as unsuitable or surplus to fertility requirements following informed consent. RCe015-A (RC-11) shows normal pluripotency marker expression and differentiation to the three germ layers in vitro and in vivo. It has a normal 46XX female karyotype and microsatellite PCR identity, HLA and blood group typing data are available. 
Resource
Resource details
RCe015-A (RC-11) was received as a fragmented cleavage stage embryo that was surplus to requirement or unsuitable for clinical use. Human embryonic stem cell (hESC) isolation, expansion and qualification was performed in a facilities whose specification, operation and monitoring complied with GMP standards enabling; i) a fully traceable procurement procedure with informed ethical consent which includes provision for commercial use, ii) detailed medical history and blood borne virus (BBV) screening of donors, and iii) compilation of a cell line history providing details on hESC manufacturing process and quality control testing regime. The embryo was grown to blastocyst stage and the cell line was derived by whole embryo outgrowth on mitotically inactivated human dermal fibroblast (HDF) feeder cells. HDFs were derived and manufactured according to GMP and had been approved for clinical use by the Food and Drug Administration, USA. During derivation on HDFs, hESCs were grown in a xeno-free cell therapy grade media (XF KODMEM) supplemented with xeno-free human recombinant bFGF. HESCs were subsequently expanded in a GMP grade serum-free medium (StemPro hESC Serum Free Medium) and xeno-free matrix (CellStart). The former contained bovine serum albumin (BSA) from a Transmissible Spongioform Encephalopathy (TSE)-free country of origin. The cell line was cryopreserved in a GMP compliant cryopreservation solution (CryoStor CS10).
By flow cytometry, RCe015-A (RC-11) expressed the pluripotency makers Oct-4, Tra-1-60 and SSEA-4 (90.0%, 87.2% and 94.9%, respectively), whereas low expression of the differentiation marker SSEA-1 (0.0%) was observed ( Fig. 1, Fig. 2 ). Differentiation to the three germ layers, endoderm, ectoderm and mesoderm, was demonstrated using embryoid body formation in vitro, and expression of the germ layer markers α-fetoprotein, β-tubulin and muscle actin was observed ( Fig. 3 , top panel). In vivo teratoma formation yielded typical hESC derived teratomas. Histological examination of fixed and stained sections clearly showed generation of cell types from ectoderm and mesoderm lineages. Endoderm differentiation was also present, but the quality of the structures meant these could not be fully characterised (Fig. 3 , bottom panels).
A microsatellite PCR profile has been obtained for the cell line, and HLA Class I and II typing is available (Table 1 ). Blood group genotyping gave the blood group O 1 O 1 , expected to give rise to blood group O + (Table 1) . The cell line is free from mycoplasma contamination as determined by RTqPCR.
Verification and authentication
The cell line was analysed for genome stability by G-banding and showed a normal 46XX female genotype (Fig. 4) . SNP genotyping was carried out using the Illumina HumanCytoSNP-12 v2.1 BeadChip and revealed a 3.6 Mb Copy-Neutral Loss of Heterozygosity (CN-LOH) on chromosome 2 (Chromosome 2p16.2-16.1) as described in Canham et al, 2015 . While CN-LOH can be constitutional acquired CN-LOH can occur during oncogenic transformation however such changes are almost exclusively telomeric or greater than 25Mb when interstitial (Kearney et al, 2011; Stephens et al, 2006) . This region was cross-referenced to the Genomic Imprinting database (http://www.geneimprint.com) (Falls et al, 1999 ) and was found not to reside in an imprinted region, although CCDC85A in the CN-LOH is predicted, but not validated, to be imprinted on this database.
Materials and methods
Ethics
Derivation of hESC from surplus to requirement and failed to fertilise/develop embryos was approved by The Scotland A Research Ethics Committee and local ethics board at participating fertility clinics and conducted under licence no R0136 from the UK HFEA with informed donor A C C E P T E D M A N U S C R I P T
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consent. The processing and storage of hESC cells for human application was conducted under licence number 22631 from the UK Human Tissue Authority.
Cell culture
Fresh embryos were cultured in Sydney cleavage medium (Cook Medical, Hertfordshire, UK) until day 3 and Sydney blastocyst medium (Cook Medical) after day 3 of development. Embryos were cultured at 36.5 -37.5°C, 5.0 ± 0.5% CO 2 , 5.0 ± 0.5% O 2 in drops under paraffin oil (Cook Medical) and transferred to fresh medium at least every 2-3 days.
By day 8 of development, embryos were placed in derivation conditions consisting of mitotically inactivated GMP grade neonatal human dermal fibroblasts (HDFs) (Forticell Biosciences, NJ, USA) on tissue culture plastic in XF KODMEM medium (Knockout-DMEM, 15% KOSR-XF, 2 mM L-glutamine, 1% MEM Non essential amino acids, 2% XF Growth Factor Cocktail, 0.1 mM β-mercaptoethanol (ThermoFisher Scientific, Paisley, UK) supplemented with 80 ng/ml human bFGF (ThermoFisher Scientific). When available, cell therapy system quality reagents were used. Assisted hatching was performed by removing the zona pellucidae mechanically using Swemed cutting tools (Vitrolife, Göteborg, Sweden).
HDF cells were cultured in DMEM (Lonza, Slough, UK), 10% Pharma grade FCS (GE Healthcare (PAA), Buckinghamshire, UK) and 2 mM L-glutamine (ThermoFisher Scientific). HDF were mitotically inactivated using gamma irradiation at 50 Gy using a Gammacell Elite 1000 machine. For use as a feeder layer, irradiated HDFs were plated at 50000 cells/cm 2 in XF KODMEM medium supplemented with 80 ng/ml human bFGF (ThermoFisher Scientific). Cells were cultured at 36.5 -37.5°C, 5.0 ± 0.5% CO 2 , 5.0 ± 0.5% O 2 and 50% medium exchanged 6 days a week.
The established cell line was expanded and banked using CellStart matrix and Stempro hESC Serum Free Medium (cell therapy system quality reagents, ThermoFisher Scientific). This contained BSA from a TSE-free country of origin. Passaging was performed mechanically using an EZ passage tool (ThermoFisher Scientific). hESC lines were expanded to 25-30 wells of a 6-well plate and cryopreserved in 0.5-1 ml Cryostor CS10 (Biolife Solution, Washington, USA) using an EF600-107 controlled rate freezer (Grant Instruments, Cambridge, UK) before being stored in a -150°C freezer (Panasonic Biomedical, Loughborough, UK).
Mycoplasma
In process mycoplasma detection was performed using Applied Biosystems PrepSEQ™ Mycoplasma Nucleic Acid Extraction Kit and MicroSEQ™ Mycoplasma Real-Time PCR Detection Kit (ThermoFisher Scientific (Applied Biosystems)) according to the manufacturer's instruction. Eurpoean pharmacopoeia (EP) mycoplasma testing was carried out by Moredun Scientific Ltd. (Edinburgh, UK), under a quality and technical agreement.
Endotoxin
Endotoxin levels were determined using the Kinetic-QCL assay (Lonza) and an incubating plate reader (BioTek ELx808) according to the manufacturer's instructions. Briefly, an unknown sample was compared with a standard curve of known levels of control endotoxin. An assay was deemed valid if the coefficient of correlation, r ≥ 0.980 and the CV (%) for the standard curve was ≤10%, and the reaction time of the negative control was greater than the reaction time of the lowest standard on the standard curve.
Flow cytometry
Pluripotency was determined using the Human and Mouse Pluripotent Stem Cell Analysis kit (BD, Oxford, UK). Oct 3/4 and SSEA-4 were included as pluripotency markers, and SSEA-1 as a differentiation marker. FITC conjugated Tra-1-60 (BD) was used as an additional pluripotency marker. Fixed and permeabilised cells were analysed using a FACS Aria flow cytometer (BD) or a Guava easyCyte flow cytometer (Millipore, Watford, UK). Percentage expression of each marker was compared to isotype control or unstained cells.
Viability
Viability was determined using the Guava ViaCount assay. Briefly, the Guava Viacount reagent (Millipore) containing a nuclear and a viability dye, was mixed with a single cell suspension, incubated for 5 minutes and analysed using the Guava easyCyte flow cytometer (Millipore). Total cell count, viable cell count and percentage viable cells was obtained.
In vitro differentiation hESCs were pre-treated for 1 h with 10 µM ROCK inhibitor in Stempro hESC SFM (ThermoFisher Scientific) and embryoid bodies (EBs) generated in ultra low attachment plates (Corning) for 7 days before being transferred into EB medium (20% FBS (GE Healthcare (PAA)), 80% KO-DMEM 1 mM Lglutamine, 3.5 µM -mercaptoethanol, 1 % nonessential amino acids (all ThermoFisher Scientific)), on glass slide tissue culture chambers (Nunc, ThermoFisher Scientific) coated with 0.2% gelatin (Sigma Aldrich, Dorset, UK) at 0.1 ml/cm 2 for 14 days.
Immunocytochemistry
Cells were fixed in 4% paraformaldehyde (ThermoFisher Scientific (Alfa Aesar)), permeabilised using 100% ethanol (ThermoFisher Scientific) and stained with AFP (1:500; Sigma), β-tubulin III (1:1000; Sigma) and muscle-specific actin (1:50; DAKO, Glostrup, Denmark) and secondary antibody anti mouse IgG-AlexaFluor 488 (1:200; Sigma). Images were acquired using a Zeiss S100 Axiovert fluorescence microscope or Nikon eC1 confocal microscope
In vivo differentiation
The developmental potential of hESC lines to form teratomas consisting of tissues representative of all three germ layers was evaluated following transplantation under kidney capsule in NOD scid gamma mice. After three months, the animals were culled and assessed for teratoma formation. Teratomas were fixed in 4% paraformaldehyde, embedded in paraffin wax and serial sections of 7μm thickness were cut according to standard procedures. For histological assessment, the tissue sections were dewaxed, rehydrated and stained with Masson staining. Tissue sections were analysed using bright field and microscopy and digital images were recorded.
SNP Genotyping and Analysis
DNA samples were assayed using the Illumina HumanCytoSNP-12 v2.1 BeadChip. Genotyping data was initially assessed using GenomeStudio genotyping module (v1.94, Illumina). Karyostudio (v1.4, Illumina) was employed to perform automatic normalisation and to identify genomic aberrations utilising default settings of the built-in cnvPartition algorithm (3.07, Illumina) to generate B-allele frequency and smoothened Log R ratio plots for detected regions. These parameters are designed to detect CNVs greater than 75 kb and CN-LOH regions larger than 1 MB with a confidence value greater than 35. All identified regions were first cross-matched to the Database of Genomic Variants (DGV; http://dgv.tcag.ca) to identify naturally-occurring structural variations in the human. CNVs that were not identified on the DGV were then checked against a list of ES cell-associated culture adaptation genomic variants published by the International Stem Cell Initiative (Amps et al, 2011) . See also Canham et al, 2015 for further details. Fig. 2 . RCe015-A (RC-11) was subjected to flow cytometry analysis for markers of pluripotency with specific antibody (top row) or isotype control (bottom row) as indicated above the histograms. Percentage staining is indicated in the Certificate of Analysis (Fig. 1) . Fig. 3 . RCe015-A (RC-11) can differentiate into the three germ layers in vitro and in vivo. Embryoid body mediated differentiation (top panel) resulted in expression of β-tubulin III (ectoderm), muscle actin (mesoderm), and α-fetoprotein (endoderm). Specific staining is shown in green, cell nuclei are counterstained with DAPI (blue). Histological sections of teratomas formed under the kidney capsule of mice yielded clear evidence for mesoderm and ectoderm differentiation and indicated that endoderm structures were also present. 
